CareTrust REIT, Inc.
CTREReal Estate Reit Healthcare Facilities
CareTrust REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $476.4 million, up 60.8% from fiscal 2024.
- Revenue
- +33.2%
- EPS
- 0.00%
- Free cash flow
- n/m
- Total debt
- +131.7%
Quarter to September 2026, against a year earlier
After hours trading: 37.22, up 1.25%, last trade 4:18pm Eastern.
Follow CTRE
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 3.60% in Q3 FY26, the lowest of these four quarters. ROE, at 7.78%, is far above it because equity is small against the capital the business uses.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | 9.2% | 9.5% | 9.1% | 7.8% |
| ROIC | 4.2% | 4.4% | 4.2% | 3.6% |
Debt
Net debt is 10.76× a year’s EBITDA. Debt is 0.39× equity.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 0.2× | 0.2× | 0.3× | 0.4× |
| Net debt / EBITDA | 5.9× | 5.3× | 8.1× | 10.8× |
Cash cycle, in days
Customers pay in 14 days and suppliers are paid in 6199. Suppliers fund 6185 days of working capital.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Cash cycle | −5006 | −3979 | −4696 | −6185 |
| Days to pay suppliers | 5014 | 3989 | 4707 | 6199 |
| Days to be paid | 8 | 10 | 11 | 14 |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has grown 9.30%; book value has grown 11.8%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | 1.0× | 1.0× | 1.0× | 1.1× |
| Book value | 1.0× | 0.9× | 1.0× | 1.1× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 7 | 7 | 4 |
| 9.20% | 9.46% | 9.09% | 7.78% | ||
| 7.45% | 7.33% | 6.70% | 5.68% | ||
ROIC |
4.17% | 4.45% | 4.15% | 3.60% | |
Return on Tangible Assets |
8.42% | 8.33% | 8.84% | 7.18% | |
Average Days of Receivables |
7.94 | 10.10 | 11.48 | 13.84 | |
Free Cash Flow per Share |
(5.40) | (4.99) | (2.32) | (7.55) | |
Free Cash Flow |
(1,099.21) | (1,112.68) | (542.91) | (1,817.28) | |
Capital Expenditures |
(1,493.24) | (1,525.69) | (989.90) | (2,318.24) | |
| Other line items | |||||
Cash ROIC |
(21.41%) | (21.17%) | (9.43%) | (23.02%) | |
Accounts Receivable Turnover |
82.55 | 63.65 | 55.34 | 40.07 | |
Accounts Payable Turnover |
0.10 | 0.12 | 0.08 | 0.07 | |
Average Days of Payables |
5,013.84 | 3,989.37 | 4,707.20 | 6,198.88 | |
Tax Rate |
(0.02) | (0.02) | (0.02) | (0.03) | |
Selling, General and Administrative Expense of Revenue |
11.01% | 11.06% | 10.68% | 9.95% | |
Interest Coverage |
7.23 | 7.09 | 7.43 | 7.17 | |
Operating CF/Net income |
1.23 | 1.24 | 1.26 | 1.38 | |
Depreciation/Fixed assets |
0.03 | 0.03 | 0.03 | 0.03 | |
Capex/Depreciation |
(14.57) | (13.30) | (7.92) | (16.95) | |
Revenue per Share |
2.34 | 2.34 | 2.44 | 2.56 | |
Operating CF per Share |
1.93 | 1.85 | 1.91 | 2.08 | |
Capex per Share |
(7.33) | (6.84) | (4.23) | (9.63) | |
Capex to Sales |
3.13 | 2.92 | 1.73 | 3.77 |